remission induction phase
The aim of induction treatment is to eliminate more than 99% of the initial burden of leukaemic cells and also to restore normal haemotopoiesis and healthy performance status.
Drugs used in remission-induction treatment include:
For the standard risk cases (on the basis that they receive intensified post-remission treatment) the three drug induction regimen is considered to be effective.
For Children with high-risk or very high-risk ALL and nearly all adult cases with ALL, four or more drugs are used for remission induction (1).
No induction therapy has been shown to be superior to the other, however:
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page